| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +19.5K | 84.1% | $51.35 | +$1M |
| Sells | 8 | -3.7K | 15.9% | $65.10 | -$241K |
| Net | -7 | +15.8K | 68.1% | +$761K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Kevin T. Conroy | President and CEO, Director | $63.6M | +$932K | +1.49% | Mar 7, 2025 |
| Sarah Condella | EVP, Human Resources | $4.76M | -$6.14K | -0.13% | Feb 28, 2025 |
| Everett Cunningham | Chief Commercial Officer | $3.81M | -$8.18K | -0.21% | Apr 30, 2024 |
| Katherine S. Zanotti | Director | $3.62M | Jun 13, 2024 | ||
| James Edward Doyle | Director | $2.88M | Jun 13, 2024 | ||
| D. Scott Coward | Director | $2.83M | -$4.03K | -0.14% | Feb 19, 2025 |
| Aaron Bloomer | EVP, Chief Financial Officer | $2.33M | Apr 15, 2025 | ||
| Jacob A. Orville | EVP, GM, Screening | $2M | -$6.14K | -0.31% | Feb 28, 2025 |
| Brian Baranick | EVP, GM, Precision Oncology | $1.82M | -$137K | -6.98% | Feb 28, 2025 |
| Jeffrey Thomas Elliott | Chief Financial Officer | $1.75M | -$8.18K | -0.47% | Apr 30, 2024 |
| Pierre Jacquet | Director | $1.73M | Jun 8, 2023 | ||
| Kathleen Sebelius | Director | $1.68M | Jun 13, 2024 | ||
| Daniel J. Levangie | Director | $1.48M | Jun 13, 2024 | ||
| Freda Lewis-Hall | Director | $1.45M | Jun 8, 2023 | ||
| James Herriott | SVP, General Counsel & Sec | $1.14M | -$1.81K | -0.16% | Feb 28, 2025 |
| Paul J. Clancy | Director | $1.06M | Jun 13, 2024 | ||
| Shacey Petrovic | Director | $842K | Jun 13, 2024 | ||
| Timothy J. Scannell | Director | $419K | Oct 31, 2023 | ||
| Thomas D. Carey | Director | $389K | Jun 2, 2021 | ||
| Kimberly J. Popovits | Director | $328K | Jan 2, 2025 | ||
| Michael J. Barber | Director | $305K | Jun 13, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|